Document is current
Any future updates will be listed below
-
Authors
Chen, Saipeng
Deng, Bingqian
Liu, Youxin
Xie, Langlang
Xu, Jie
Hu, Ruimin
Zhao, Fuhan
Song, Guojing
Ni, Rongrong
Liu, Heting
Zhou, Zhansong
Huang, Gang
Shen, Wenhao https://orcid.org/0000-0002-4410-128X
-
Funding
Funding for this research was provided by:
the Nature Science Foundation of Chongqing (cstc2021jcyj-msxmX0052)
the Chongqing Innovation Leading Talent Project (CQYC20220303706)
the Key Support Object of AMU (410301060133)
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 14 July 2025
First Online: 5 August 2025
Declarations
:
: The human study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. The tumor tissue microarray of patients with prostate cancer used in this study was provided by Changsha Yaxiang Biotechnology Co., Ltd. This study was reviewed and approved by the Ethics Committee of the company (ethics approval number Csyayj2024022). The animal study was approved by the Animal Experiment Welfare and Ethics Committee of Army Medical University (AMUWEC20232943). All animal experiments were conducted in compliance with the requirements of Chinese microbiology.
: The authors declare that they have no potential conflicts of interest.
